Cytomel, Triostat (liothyronine) is a small molecule pharmaceutical. Liothyronine was first approved as Cytomel on 1982-01-01. It is used to treat autoimmune thyroiditis, goiter, myxedema, thyroid neoplasms, and thyrotoxicosis in the USA. The pharmaceutical is active against thyroid hormone receptor beta and thyroid hormone receptor alpha.
|Trade Name||Cytomel, Triostat|
|Indication||autoimmune thyroiditis, goiter, myxedema, thyroid neoplasms, thyrotoxicosis|